Clinical Trial Update: A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 dose-ranging study in patients with Diabetic Peripheral Neuropathic Pain sponsored by Lexicon Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• Undisclosed Lexicon study drug

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED